慢性疾患管理市場

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Chronic Disease Management Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Global Chronic Disease Management Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Global Chronic Disease Management Market - Breakup by Type
6.1 Solutions
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2025-2033)
6.2 Services
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2025-2033)
6.3 Attractive Investment Proposition by Type

7 Global Chronic Disease Management Market - Breakup by Disease Type
7.1 Cardiovascular Diseases 
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2025-2033)
7.2 Diabetes
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2025-2033)
7.3 Cancer
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2019-2024)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2025-2033)
7.4 Asthma
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2019-2024)
7.4.3 Market Segmentation
7.4.4 Market Forecast (2025-2033)
7.5 Chronic Obstructive Pulmonary Disorders
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2019-2024)
7.5.3 Market Segmentation
7.5.4 Market Forecast (2025-2033)
7.6 Others
7.6.1 Historical and Current Market Trends (2019-2024)
7.6.2 Market Forecast (2025-2033)
7.7 Attractive Investment Proposition by Disease Type

8 Global Chronic Disease Management Market - Breakup by Deployment Type
8.1 On-premises
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2025-2033)
8.2 Cloud-based 
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2025-2033)
8.3 Web-based
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2025-2033)
8.8 Attractive Investment Proposition by Solution Type

9 Global Chronic Disease Management Market - Breakup by End User
9.1 Healthcare Providers
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2019-2024)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2025-2033)
9.2 Healthcare Payers
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2019-2024)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2025-2033)
9.3 Others
9.3.1 Historical and Current Market Trends (2019-2024)
9.3.2 Market Forecast (2025-2033)
9.4 Attractive Investment Proposition by End User

10 Global Chronic Disease Management Market – Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Drivers
10.1.1.2 Historical and Current Market Trends (2019-2024)
10.1.1.3 Market Breakup by Type
10.1.1.4 Market Breakup by Disease Type
10.1.1.5 Market Breakup by Deployment Type
10.1.1.6 Market Breakup by End User
10.1.1.7 Key Players
10.1.1.8 Market Forecast (2025-2033)
10.1.2 Canada
10.1.2.1 Market Drivers
10.1.2.2 Historical and Current Market Trends (2019-2024)
10.1.2.3 Market Breakup by Type
10.1.2.4 Market Breakup by Disease Type
10.1.2.5 Market Breakup by Deployment Type
10.1.2.6 Market Breakup by End User
10.1.2.7 Key Players
10.1.2.8 Market Forecast (2025-2033)
10.2 Europe
10.2.1 Germany
10.2.1.1 Market Drivers
10.2.1.2 Historical and Current Market Trends (2019-2024)
10.2.1.3 Market Breakup by Type
10.2.1.4 Market Breakup by Disease Type
10.2.1.5 Market Breakup by Deployment Type
10.2.1.6 Market Breakup by End User
10.2.1.7 Key Players
10.2.1.8 Market Forecast (2025-2033)
10.2.2 France
10.2.2.1 Market Drivers
10.2.2.2 Historical and Current Market Trends (2019-2024)
10.2.2.3 Market Breakup by Type
10.2.2.4 Market Breakup by Disease Type
10.2.2.5 Market Breakup by Deployment Type
10.2.2.6 Market Breakup by End User
10.2.2.7 Key Players
10.2.2.8 Market Forecast (2025-2033)
10.2.3 United Kingdom
10.2.3.1 Market Drivers
10.2.3.2 Historical and Current Market Trends (2019-2024)
10.2.3.3 Market Breakup by Type
10.2.3.4 Market Breakup by Disease Type
10.2.3.5 Market Breakup by Deployment Type
10.2.3.6 Market Breakup by End User
10.2.3.7 Key Players
10.2.3.8 Market Forecast (2025-2033)
10.2.4 Italy
10.2.4.1 Market Drivers
10.2.4.2 Historical and Current Market Trends (2019-2024)
10.2.4.3 Market Breakup by Type
10.2.4.4 Market Breakup by Disease Type
10.2.4.5 Market Breakup by Deployment Type
10.2.4.6 Market Breakup by End User
10.2.4.7 Key Players
10.2.4.8 Market Forecast (2025-2033)
10.2.5 Spain
10.2.5.1 Market Drivers
10.2.5.2 Historical and Current Market Trends (2019-2024)
10.2.5.3 Market Breakup by Type
10.2.5.4 Market Breakup by Disease Type
10.2.5.5 Market Breakup by Deployment Type
10.2.5.6 Market Breakup by End User
10.2.5.7 Key Players
10.2.5.8 Market Forecast (2025-2033)
10.2.6 Others
10.2.6.1 Historical and Current Market Trends (2019-2024)
10.2.6.2 Market Forecast (2025-2033)
10.3 Asia Pacific
10.3.1 China
10.3.1.1 Market Drivers
10.3.1.2 Historical and Current Market Trends (2019-2024)
10.3.1.3 Market Breakup by Type
10.3.1.4 Market Breakup by Disease Type
10.3.1.5 Market Breakup by Deployment Type
10.3.1.6 Market Breakup by End User
10.3.1.7 Key Players
10.3.1.8 Market Forecast (2025-2033)
10.3.2 Japan
10.3.2.1 Market Drivers
10.3.2.2 Historical and Current Market Trends (2019-2024)
10.3.2.3 Market Breakup by Type
10.3.2.4 Market Breakup by Disease Type
10.3.2.5 Market Breakup by Deployment Type
10.3.2.6 Market Breakup by End User
10.3.2.7 Key Players
10.3.2.8 Market Forecast (2025-2033)
10.3.3 India
10.3.3.1 Market Drivers
10.3.3.2 Historical and Current Market Trends (2019-2024)
10.3.3.3 Market Breakup by Type
10.3.3.4 Market Breakup by Disease Type
10.3.3.5 Market Breakup by Deployment Type
10.3.3.6 Market Breakup by End User
10.3.3.7 Key Players
10.3.3.8 Market Forecast (2025-2033)
10.3.4 South Korea
10.3.4.1 Market Drivers
10.3.4.2 Historical and Current Market Trends (2019-2024)
10.3.4.3 Market Breakup by Type
10.3.4.4 Market Breakup by Disease Type
10.3.4.5 Market Breakup by Deployment Type
10.3.4.6 Market Breakup by End User
10.3.4.7 Key Players
10.3.4.8 Market Forecast (2025-2033)
10.3.5 Australia
10.3.5.1 Market Drivers
10.3.5.2 Historical and Current Market Trends (2019-2024)
10.3.5.3 Market Breakup by Type
10.3.5.4 Market Breakup by Disease Type
10.3.5.5 Market Breakup by Deployment Type
10.3.5.6 Market Breakup by End User
10.3.5.7 Key Players
10.3.5.8 Market Forecast (2025-2033)
10.3.6 Indonesia
10.3.6.1 Market Drivers
10.3.6.2 Historical and Current Market Trends (2019-2024)
10.3.6.3 Market Breakup by Type
10.3.6.4 Market Breakup by Disease Type
10.3.6.5 Market Breakup by Deployment Type
10.3.6.6 Market Breakup by End User
10.3.6.7 Key Players
10.3.6.8 Market Forecast (2025-2033)
10.3.7 Others
10.3.7.1 Historical and Current Market Trends (2019-2024)
10.3.7.2 Market Forecast (2025-2033)
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Drivers
10.4.1.2 Historical and Current Market Trends (2019-2024)
10.4.1.3 Market Breakup by Type
10.4.1.4 Market Breakup by Disease Type
10.4.1.5 Market Breakup by Deployment Type
10.4.1.6 Market Breakup by End User
10.4.1.7 Key Players
10.4.1.8 Market Forecast (2025-2033)
10.4.2 Mexico
10.4.2.1 Market Drivers
10.4.2.2 Historical and Current Market Trends (2019-2024)
10.4.2.3 Market Breakup by Type
10.4.2.4 Market Breakup by Disease Type
10.4.2.5 Market Breakup by Deployment Type
10.4.2.6 Market Breakup by End User
10.4.2.7 Key Players
10.4.2.8 Market Forecast (2025-2033)
10.4.3 Others
10.4.3.1 Historical and Current Market Trends (2019-2024)
10.4.3.2 Market Forecast (2025-2033)
10.5 Middle East and Africa
10.5.1.1 Market Drivers
10.5.1.2 Historical and Current Market Trends (2019-2024)
10.5.1.3 Market Breakup by Type
10.5.1.4 Market Breakup by Disease Type
10.5.1.5 Market Breakup by Deployment Type
10.5.1.6 Market Breakup by End User
10.5.1.7 Market Breakup by Country
10.5.1.8 Key Players
10.5.1.9 Market Forecast (2025-2033)
10.6 Attractive Investment Proposition by Region

11 Global Chronic Disease Management Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Share by Key Players
11.4 Market Player Positioning
11.5 Top Winning Strategies
11.6 Competitive Dashboard
11.7 Company Evaluation Quadrant

12 Profiles of Key Players
12.1 Altruista Health Inc.
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Cliexa Inc
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 ExlService Holdings, Inc
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Business Strategies
12.3.4 Financials
12.3.5 SWOT Analysis
12.3.6 Major News and Events
12.4 Infosys Limited
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Business Strategies
12.4.4 Financials
12.4.5 SWOT Analysis
12.4.6 Major News and Events
12.5 International Business Machines Corporation
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Business Strategies
12.5.4 Financials
12.5.5 SWOT Analysis
12.5.6 Major News and Events
12.6 Koninklijke Philips N.V.
12.6.1 Business Overview
12.6.2 Product Portfolio
12.6.3 Business Strategies
12.6.4 Financials
12.6.5 SWOT Analysis
12.6.6 Major News and Events
12.7 Mines & Associates Inc.
12.7.1 Business Overview
12.7.2 Product Portfolio
12.7.3 Business Strategies
12.7.4 SWOT Analysis
12.7.5 Major News and Events
12.8 ScienceSoft USA Corporation
12.8.1 Business Overview
12.8.2 Product Portfolio
12.8.3 Business Strategies
12.8.4 SWOT Analysis
12.8.5 Major News and Events
12.9 TCS Healthcare Technologies
12.9.1 Business Overview
12.9.2 Product Portfolio
12.9.3 Business Strategies
12.9.4 SWOT Analysis
12.9.5 Major News and Events
12.10 Zeomega Inc.
12.10.1 Business Overview
12.10.2 Product Portfolio
12.10.3 Business Strategies
12.10.4 SWOT Analysis
12.10.5 Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

13 Global Chronic Disease Management Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1    Overview
13.1.2    Drivers
13.1.3    Restraints
13.1.4    Opportunities
13.1.5    Impact Analysis
13.2 Porters Five Forces Analysis
13.2.1    Overview
13.2.2    Bargaining Power of Buyers
13.2.3    Bargaining Power of Suppliers
13.2.4    Degree of Competition
13.2.5    Threat of New Entrants
13.2.6    Threat of Substitutes
13.3 Value Chain Analysis

14 Strategic Recommendations

15 Appendix